Omics, Bioinformatics, & Computational Biology:

More Info
Bruce Cohen, M.D., Ph.D.

Robertson-Steele Professor of Psychiatry, HMS; Psychiatrist and Director of the Program for Neuropsychiatric Research

Shervert H. Frazier Research Institute

Molecular, cellular, animal models of mood and psychotic disorders

More Info
Steve Haggarty, PhD

Director, Chemical Neurobiology for the Stanley Center for Psychiatric Research at the Broad Institute
Assistant Professor of Neurology at HMS, Assistant in Neuroscience at MGH Center for Human Genetic Research
Affiliate Faculty member of the Harvard Stem Cell Institute

Chemical Genomics of Neuropsychiatric & Neurological Disease

Center for Human Genetic Research

molecular mechanisms underlying neuroplasticity, use of synthetic chemistry and genetics to investigate neurocircuitry underlying mood and memory

More Info
Kasper Lage, PhD

Director of Bioinformatics at MGH; Associate Professor at HMS

Bioinformatics, interpreting large genomic datasets with the aim of informing biology and medicine, genomic datasets, surgery, genetic datasets to deduce networks driving congenital heart diseases, autoimmune disorders, and schizophrenia

More Info
Steve McCarroll, PhD

Director of Genetics, Stanley Center for Psychiatric Research at the Broad Institute
Assistant Professor of Genetics, Harvard Medical School

McCarroll Genetics Lab

genetic structural variation and links to molecular phenotypes and disease risk

More Info
Benjamin Neale, PhD

Assistant Professor, Harvard Medical School
Associate Member, Broad Institute
Director of Population Genetics, Stanley Center for Psychiatric Research, Broad Institute

Neale Lab

Statistical methodology for genetic studies, with particular focus on ADHD, Autism, and Schizophrenia.

More Info
Roy Perlis, MD, MSc

Director, Psychiatry Center for Experimental Drugs and Diagnostics, MGH
Associate Director, Psychiatric Genetics Program in Mood and Anxiety Disorders, MGH
Associate Professor of Psychiatry, Harvard Medical School

MGH Psychiatry Center for Quantitative Health

Patient-derived cellular models of disease using induced pluripotent stem cells; pharmacogenomics and clinical risk stratification; proof-of-concept/first-in-human clinical trials

More Info
Peter Siekmeier, MS, MD

Director, Laboratory for Computational Neuroscience, McLean Hospital
Instructor in Psychiatry, Harvard Medical School

Schizophrenia and Bipolar Disorder Inpatient Program

Schizophrenia and Bipolar Disorder Inpatient Program

More Info
Jordan Smoller, M.D., Sc.D.

Broad/MGH, Dept. of Psychiatry

Professor of Psychiatry, HMS; Professor, Department of Epidemiology, Harvard School of Public Health; Associate Chief for Research, Department of Psychiatry, MGH; Director, Psychiatric Genetics, MGH; Director, Psychiatric and Neurodevelopmental Genetics Unit (PNGU), MGH; Co-Director, Genetics and Genomics Unit Clinical Research Program, MGH; Associate Member, Broad Institute; Senior Scientist, Stanley Center for Psychiatric Research, Broad/MIT

Psychiatric and Neurodevelopmental Genetics Unit

psychiatric and genetic epidemiology, clinical psychiatric research, statistical genetics, linage and association studies, imaging genetics, and pharmacogenetics. Design and conduct of psychiatric genetic studies, including studies of behavioral and neuroimaging intermediate phenotypes.

More Info
Florence Wagner, PhD

Director of Medicinal Chemistry, Broad Institute

novel therapeutics for psychiatric disorders, and, at CDoT, on novel strategies to treat inflammatory and metabolic disorders